Overall rank by patents
#902
Across all tracked assignees
USPTO PatentsView assignee record - 499 granted patents across 71 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Omron holds 499 US patents across 71 technology areas, rank #902 of 50,000 tracked assignees.
Omron Healthcare Co., Ltd. has been granted 499 US utility patents between 2015 and 2025, placing Omron Healthcare Co., Ltd. at rank #902 across all assignees tracked by PlainPatent. This portfolio spans 71 distinct Cooperative Patent Classification (CPC) subclasses, averaging 7.0 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Omron Healthcare Co., Ltd. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Omron sits between China Petroleum & Chemical Corporation (500 patents, rank #898) and Wilus Institute OF Standards AND Technology Inc. (496 patents, rank #906) - the closest US assignees by grant volume. The composite Innovation Score of 59.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 300 grants, compared with 199 in the 2015–2019 window, a +51% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Omron Healthcare Co., Ltd.'s 7.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 71 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Omron Healthcare Co., Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CHINA PETROLEUM & CHEMICAL CORPORATION
500 patents
UNITED PARCEL SERVICE OF AMERICA, INC.
500 patents
Dalian University of Technology
499 patents
NHK SPRING CO., LTD.
499 patents
OMRON HEALTHCARE Co., Ltd.
499 patents
Eastman Chemical Company
498 patents
UNIVERSITY OF MARYLAND, BALTIMORE
497 patents
Symbol Technologies, LLC
496 patents
WILUS INSTITUTE OF STANDARDS AND TECHNOLOGY INC.
496 patents
What this shows Omron holds 499 patents at rank #902, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #902 in granted patent volume.
Other assignees with the most granted patents in Omron's primary technology class.
Omron's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
60 Top 4% higher than 96% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 55 | 11.0% |
| 2016 | 46 | 9.2% |
| 2017 | 24 | 4.8% |
| 2018 | 39 | 7.8% |
| 2019 | 35 | 7.0% |
| 2020 | 48 | 9.6% |
| 2021 | 51 | 10.2% |
| 2022 | 68 | 13.6% |
| 2023 | 48 | 9.6% |
| 2024 | 67 | 13.4% |
| 2025 | 18 | 3.6% |
Top 15 of 71 technology areas
Overall rank by patents
#902
Across all tracked assignees
59.8 out of 100
How to use this portfolio
Omron's 499 grants land it in the top 4% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.